EUVIMEDEUVIMED entdecken
Leitlinie

Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for 2021–2023

Xin Xing iD, Guohua Zhang, Weize Kong, Liping Guo iD, Xiuxia Li iD, Zhipeng Wei, Yongbin Lu iD, Howard White iD, Yaolong Chen, Kehu Yang

Journal of Evidence-Based Medicine · 2025

DOI: 10.1111/jebm.70062 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Evidence-Based Medicine, 2025. Verfasst von Xin Xing und 9 weiteren Autor:innen. Beteiligte Einrichtung: Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, P. R. China. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, Economics, Medical, Evidence-Based Medicine. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Social Science Fund of China, the Medical and Health Technology Innovation Engineering of the Chinese Academy of Medical Sciences, and the Evidence Evaluation and Guidelines Innovation Unit…, National Office for Philosophy and Social Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

While prior investigations into the reporting of health economics (HE) have predominantly focused on guideline analyses at singular institutional or national levels, this study extends its scope to encompass diverse guidance documents issued transnationally across multiple institutions. Specifically, we evaluated the reporting of HE evidence in international clinical practice guidelines (CPGs) and expert consensus statements published between 2021 and 2023. The findings aim to inform the future revisions and development of such documents.

Methods

A systematic PubMed search identified relevant CPGs and expert consensus statements within a specified period. Two independent researchers screened the literature, extracted economic evidence integrated into these documents, and employed descriptive analysis to summarize the reporting characteristics.

Results

Of the 8931 screened publications, 3119 (34.9%) reported HE evidence. Among these 3119 publications, 237 (7.6%) incorporated HE evidence in formulating recommendations, 220 (7.1%) utilized HE evidence for evidence grading, and 2581 (82.8%) referenced HE evidence in explanatory notes accompanying the recommendations.

Conclusions

Current CPGs and expert consensus statements exhibit low rates of HE evidence reporting, indicating that most international guideline developers have overlooked their applications. HE evidence—through cost‐effectiveness and cost‐utility analyses—can optimize medical resource allocation, support clinicians in patient‐centered economic decision‐making, and enhance health outcomes. Future guideline development should prioritize HE evidence integration to advance the scientific rigor and clinical applicability of the recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as TopicEconomics, MedicalEvidence-Based MedicineHumansCost-Benefit Analysis

Stichwörter der Autor:innen

clinical practice guidelinesevidence‐based medicineexpert consensus statementshealth economicsreporting quality

Autor:innen und Institutionen

  • Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, P. R. China.
  • Center for Evidence Based Social Science of Lanzhou University, Lanzhou University, Lanzhou, Gansu, P. R. China.
  • WHO Collaborating Center for Guideline Implementation and Knowledge Translation, Lanzhou, Gansu, P. R. China.
  • Department of Epidemiology and Evidence-Based Medicine, School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, P. R. China.
  • Department of Comparative Medicine, First School of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, P. R. China.
  • Key Laboratory of Evidence Based Medicine of Gansu Province, Lanzhou, Gansu, P. R. China.

ORCID-Profile: Xin Xing, Liping Guo, Xiuxia Li, Yongbin Lu, Howard White

Förderung

  • National Social Science Fund of China
  • the Medical and Health Technology Innovation Engineering of the Chinese Academy of Medical Sciences, and the Evidence Evaluation and Guidelines Innovation Unit…
  • National Office for Philosophy and Social Sciences

Zitieren

APA

Xing, X., Zhang, G., Kong, W., Guo, L., Li, X., Wei, Z., Lu, Y., White, H., Chen, Y., & Yang, K. (2025). Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for 2021–2023. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70062

Vancouver

Xing X, Zhang G, Kong W, Guo L, Li X, Wei Z, et al. Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for 2021–2023. Journal of Evidence-Based Medicine. 2025. doi:10.1111/jebm.70062

BibTeX
@article{Xing2025,
  author = {Xing, Xin and Zhang, Guohua and Kong, Weize and Guo, Liping and Li, Xiuxia and Wei, Zhipeng and Lu, Yongbin and White, Howard and Chen, Yaolong and Yang, Kehu},
  title = {Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for 2021–2023},
  journal = {Journal of Evidence-Based Medicine},
  year = {2025},
  doi = {10.1111/jebm.70062}
}
Kostenlos starten →